A Phase III, Randomized, Open-label, Active-controlled, Multicenter Trial to Study the Contraceptive Efficacy and Safety of the Commercial Batch of Oral Tablets of MK-8175A (Nomegestrol Acetate - 17beta-estradiol) in Healthy, Sexually-active Women Aged 18-50 Years

Trial Profile

A Phase III, Randomized, Open-label, Active-controlled, Multicenter Trial to Study the Contraceptive Efficacy and Safety of the Commercial Batch of Oral Tablets of MK-8175A (Nomegestrol Acetate - 17beta-estradiol) in Healthy, Sexually-active Women Aged 18-50 Years

Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Estradiol/nomegestrol (Primary) ; Ethinylestradiol; Ethinylestradiol/norethisterone; Ferrous fumarate
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 03 Dec 2014 Status changed from completed to discontinued, as reported by ClinicalTrials.gov record.
    • 20 Feb 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 24 Apr 2013 Planned End Date changed from 1 May 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top